12 April 2002 Early neuroimaging diagnosis of Alzheimer's disease
Author Affiliations +
Proceedings Volume 4536, International Workshop on Photonics and Imaging in Biology and Medicine; (2002) https://doi.org/10.1117/12.462540
Event: International Workshop on Photonics and Imaging in Biology and Medicine, 2001, Wuhan, China
Abstract
Neuroimaging has played an important role in evaluating the Alzheimer's disease (AD) patients, and its uses are growing. Magnetic resonance imaging (MRI) may show the presence of cerebral infarcts and white matter disease. Single photon emission computed tomography (SPECT) and positron emission tomography (PET), which visualize such cerebral functions as glucose metabolism and blood flow, may provide positive evidence to support the diagnosis of AD. Electrical impedance tomography (EIT) is a recently developed technique which enables the internal impedance of an object to be imaged noninvasively.
© (2002) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jianling Jiao, Jianling Jiao, Timon Cheng-Yi Liu, Timon Cheng-Yi Liu, Yan Li, Yan Li, Songhao Liu, Songhao Liu, } "Early neuroimaging diagnosis of Alzheimer's disease", Proc. SPIE 4536, International Workshop on Photonics and Imaging in Biology and Medicine, (12 April 2002); doi: 10.1117/12.462540; https://doi.org/10.1117/12.462540
PROCEEDINGS
6 PAGES


SHARE
Back to Top